- Organizations: RetinAI
Business
EssilorLuxottica purchases RetinAI
Ikarian subsidiary is the developer of the FDA-cleared Discovery platform, an AI-based imaging data management system for diagnosing and monitoring ophthalmic disease progression.Products
RetinAI launches AI-based platform for clinical decision workflows
Multi-modality software platform features a faster, volumetric, and integrated analysis of OCT images for ophthalmology and optometric practices.Research